Qvr LLC Bristol Myers Squibb CO Transaction History

Qvr LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $317,147 - $359,584	6,610 New	6,610 $358,000
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $9,929 - $11,758	145 New	145 $10,000
Q4 2021 Jan 31, 2022	SELL	$53.63 - $62.52 $227,712 - $265,459	-4,246 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$59.17 - $69.31 $147,510 - $172,789	2,493 Added 142.21%	4,246 $251,000
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $101,218 - $114,698	1,753 New	1,753 $109,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Qvr LLC, based on Form 13F filings with the SEC.

Stay updated on Qvr LLC with notifications on news.